Chemical and Pharmaceutical Bulletin · 2003 · 221 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoverySynthetic Medicinal ChemistryLead Compound DesignOncology PharmacologyAnticancer Compound ScreeningLethal Concentration AnalysisLethal Concentration AssessmentLethal Concentration MedianMedian Lethal DosePyrazole ChemistryPyrazole SynthesisVascular Endothelial Growth Factor
Several 1,3,4-trisubstituted pyrazole derivatives were synthesized and screened for their cytotoxic effect in a primary 3 tumor cell line test at 10(-4) M drug concentration. Compounds 19 and 20 reduced the growth of one or more of these cell lines to less than 32% and escalated up to evaluation in the full panel of 60 human tumor cell lines at a minimum of 5 concentrations at 10 fold dilutions. Compound N'-(1-[1-[4-nitrophenyl]-3-phenyl-1H-pyrazol-4-yl]methylene)-2-chlorobenzohydrazide 19 proved to be the most active of these derivatives with full panel median growth inhibition (GI50), total growth concentration (TGI) and median lethal concentration (LC50) mean graph mid-point (MG-MID) of 3.79, 12.5 and 51.5 microM, respectively. In addition, compounds 19, 39, 40, 41, 43, 45, 47 were tested for their antiangiogenic properties by testing their ability to inhibit human umbilical vein endothelial cells (HUVECs) proliferation, cord formation and migration in response to chemoattractant. 3-Acetyl-2-(1-(4-nitrophenyl)-3-phenylpyrazol-4-yl)-5-(4-pyridyl)-1,3,4-oxadiazoline 39 showed significant antiangiogenic profile at non-cytotoxic doses, with HUVEC proliferation inhibition IC50 of 7.60 microM, chemotaxis IC50 of 0.86 microM and was superior to the reference celecoxib 2 in both tests. Furthermore, in contrary to the references TNP-470 and celecoxib, all the tested compounds interfered with the migratory function of HUVECs in response to vascular endothelium growth factor (VEGF) rather than the endothelial cells proliferation.
18
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
Dorina Belotti, Veronica Vergani, Teresa Drudis et al. · PubMed · 1996 · 646 citations
Medicine, Oncology, Pharmacology +13
Ruo Li Bai, Kenneth D. Paull, Cherry L. Herald et al. · Journal of Biological Chemistry · 1991 · 377 citations · Full text